LEADING NATIONAL PHASE I PROGRAM Icon operates Australia’s largest private Phase I clinical trials program, which saw 52% growth with the addition of Ashford Cancer Centre Research (ACCR) based at the Tennyson Centre in Adelaide, South Australia. Icon’s Phase I trials are led by internationally recognised clinicians, A/Prof Jim Coward (South Brisbane, Qld) and Dr Gonzalo Tapia Rico ( Adelaide (Tennyson) and Windsor Gardens, SA) who treat a broad range of solid tumour malignancies and continue to amplify our impact and operate unparalleled, stable and growing private Phase I units. The group continues to expand the Phase I portfolio, contributing 38% of the annual accrual across participating early phase locations at Queensland sites - South Brisbane, Southport, Wesley, Chermside and South Australia’s centres at Adelaide (Tennyson) and Windsor Gardens. This portfolio continues to thrive, with Icon’s ongoing relationships with sponsors including, but not limited to; AbbVie, Akesobio, Atridia, BeiGene and CStone. Notably 35 participants, one third of the annual accrual to Phase I trials, were from five Akesobio trials conducted across both the Icon Cancer Centre Adelaide (Tennyson) and Icon Cancer Centre South Brisbane clinics.
26
ICON ANNUAL RESEARCH REPORT 2021
